Prognostic impact of high p16/cyclin D1 index in breast cancer
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Gi Jeong | - |
dc.contributor.author | Kim, Dong-Hoon | - |
dc.contributor.author | Min, Kyueng-Whan | - |
dc.contributor.author | Kim, Se Hoon | - |
dc.date.accessioned | 2022-07-10T15:02:03Z | - |
dc.date.available | 2022-07-10T15:02:03Z | - |
dc.date.created | 2021-05-12 | - |
dc.date.issued | 2019 | - |
dc.identifier.issn | 1936-2625 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hanyang/handle/2021.sw.hanyang/148666 | - |
dc.description.abstract | Proteins p16 and cyclin D1 (CCND1) are known to tightly regulate the G1/S transition during the cell cycle, but their role in breast cancer development and progression is not clear. We investigated 224 cases of breast cancer from the Kangbuk Samsung Medical Center between 2000-2005. Expression levels of p16 and CCND1 were assessed by tissue microarray-based immunohistochemistry. A p16/CCND1 index was divided into low- and high-expression groups using receiver operating characteristic curves. The p16/CCND1 index was significantly different across molecular subtypes and a high p16/CCND1 index was statistically correlated with survival rates. This p16/CCND1 index may be an indicator of poor patient outcome and thus, represents a potential therapeutic target. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | E-CENTURY PUBLISHING CORP | - |
dc.title | Prognostic impact of high p16/cyclin D1 index in breast cancer | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Min, Kyueng-Whan | - |
dc.identifier.wosid | 000473287100030 | - |
dc.identifier.bibliographicCitation | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, v.12, no.6, pp.2224 - 2232 | - |
dc.relation.isPartOf | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | - |
dc.citation.title | INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY | - |
dc.citation.volume | 12 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 2224 | - |
dc.citation.endPage | 2232 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalResearchArea | Pathology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.relation.journalWebOfScienceCategory | Pathology | - |
dc.subject.keywordPlus | CYCLIN D1 | - |
dc.subject.keywordPlus | RETINOBLASTOMA PROTEIN | - |
dc.subject.keywordPlus | P16 PROTEINS | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | OVEREXPRESSION | - |
dc.subject.keywordPlus | CARCINOMA | - |
dc.subject.keywordPlus | METHYLATION | - |
dc.subject.keywordPlus | RB | - |
dc.subject.keywordPlus | PROGRESSION | - |
dc.subject.keywordPlus | P16(INK4A) | - |
dc.subject.keywordAuthor | Breast cancer | - |
dc.subject.keywordAuthor | p16 | - |
dc.subject.keywordAuthor | cyclin D1 | - |
dc.subject.keywordAuthor | index | - |
dc.subject.keywordAuthor | prognosis | - |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949626/ | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
222, Wangsimni-ro, Seongdong-gu, Seoul, 04763, Korea+82-2-2220-1365
COPYRIGHT © 2021 HANYANG UNIVERSITY.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.